$10.780
-0.613 (-5.69%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BHVN Prediction & Forecast by Similar Chart Analysis
Alphio's BHVN stock price prediction model matches the current Biohaven Ltd. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.64 (-1.26%). The 1-week path is $10.43 (-3.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Biohaven Ltd. Stock?
Biohaven Ltd is not a good buy right now due to significant risks and poor performance indicators. The current price is $10.78, and the stock has seen a 1-year change of -38.54%. Additionally, the RSI is at 25.869, indicating the stock is oversold, but the recent FDA clinical hold on its epilepsy drug has led to a 16% drop in stock value, creating uncertainty around future performance.
BHVN stock price ended at $10.78 on Friday, after losing -5.69%
Biohaven Ltd. (BHVN) last closed at $10.78, losing -5.69%. These facts feed the 1-day and 1-week BHVN price prediction above.
Analyst Consensus
Biohaven Ltd. (BHVN): 5 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Biohaven Ltd. (BHVN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BHVN, ranked by similarity.
Seasonality analysis for BHVN
Historically the probability of a positive October return for BHVN is 58.62%. February offers the highest probability of a positive month at 87.93%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.